Compare AERT & CCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AERT | CCM |
|---|---|---|
| Founded | 2012 | 1997 |
| Country | Singapore | China |
| Employees | N/A | N/A |
| Industry | Professional Services | Medical/Nursing Services |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.9M | 23.8M |
| IPO Year | N/A | 2009 |
| Metric | AERT | CCM |
|---|---|---|
| Price | $0.54 | $3.82 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 130.4K | 5.2K |
| Earning Date | 02-13-2026 | 09-26-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $69,346,000.00 | $51,056,841.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.46 | $3.54 |
| 52 Week High | $2.67 | $10.77 |
| Indicator | AERT | CCM |
|---|---|---|
| Relative Strength Index (RSI) | 42.21 | 36.40 |
| Support Level | $0.54 | $3.61 |
| Resistance Level | $0.59 | $4.51 |
| Average True Range (ATR) | 0.05 | 0.33 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 11.75 | 0.00 |
Aeries Technology Inc is a professional and management services partner offering a range of management consultancy services for private equity sponsors and their portfolio companies with engagement models that are designed to provide a mix of deep vertical specialty, functional expertise, and digital systems and solutions to scale, optimize and transform a client's business operations. It supports and drives its client's growth across the globe by providing a range of management consultancy services involving professional advisory services and operations management services to build and manage dedicated delivery centers in appropriate locations based on customer business needs.
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.